Government Programs Summit (sponsor)

I am pleased to welcome back IIR as a Drug Channels sponsor for its 4th Annual Government Programs Summit. The event will be held March 14-16, 2012, in Baltimore.

IIR tells me that this will be the first conference since CMS issued its Proposed Rule. Comments are due by April 2, so this will be a very timely networking and learning event. Plus, you'll hear directly from CMS Policy, Technical and Operational officers. For some fun pre-reading, see the five expert analyses in More Analysis of the Proposed AMP Rule.

So, get your AMP on and register today! IIR is offering a special 25% discount to Drug Channels readers. Just register with your VIP code: XP1751DRUG. Thanks, IIR!

Full details from IIR below.

OFFICIAL DESCRIPTION FROM IIR

The GP Summit is coming at a timely point for the drug pricing and contracting sector. When CMS released its Proposed Rule just a few weeks ago, the world of government programs initially sighed in relief, as the long wait was finally over. But now, you want some answers. In these initial weeks between its release and when comments are due on April 2nd, IIR’s Government Programs Summit is the FIRST event where you will hear industry experts interpret the Proposed Rule and its implications for the pharmaceutical industry.

While CMS Policy, Technical and Operational officers will be presenting, they cannot comment on the Proposed Rule, but will be able to provide general updates on government program topics. But no fear! The program is full of industry insiders prepared to help you interpret the rules and how they might affect your business.

But that’s not all you’ll see in Baltimore starting March 14...

Download the Government Programs Summit 2012 agenda here to see what else they have to offer.

Government Programs Summit has more than 25 Government Officials from the following agencies: CMS, State Pharmacy Representatives, OIG, OPA, PVP, PSSC and VA so you will be able to:

• Decipher 340B program changes
• Improve processes for Medicare Part D Rebates
• Comply with False Claims Act Violations and Kickback Statue Violations
• Manage the Medicaid Managed Care Utilization Claims invoices
• Calculate the new Medicare Part B and ASP definition for coverage and coding
• Present new State Reporting requirements
• Validate the Pharmaceutical Industry Fee
• Deliberate the potential to change the reimbursement mechanism (AAC)

Staying compliant and staying in the know about upcoming regulatory changes are fundamental needs, goals, and desires for branded and generic manufacturers.

Register today for the only event that leaves you with information that comes straight from the government, back to your office.